RefleXion™X1 is world’s first biology-guided radiotherapy (BgRT) machine that’s expected to improve treatment and expand options for patients with metastatic disease by incorporating PET, CT & radiation in one device.
The brain-computer interface user was able to transfer objects with a robotic arm at twice the speed of doing it without the tactile feedback.
There is no long-term benefit to surgically placing tubes in a young child’s ears to reduce recurrent ear infections, compared with giving oral antibiotics, a randomized trial determined.
A paper published today in JAMA Network Open presents early results of the global effort to gather information about the incidence, severity and outcomes of neurological manifestations of COVID-19 disease.
Mutations in a protein called GEMIN5 cause developmental delay and loss of coordination in young children.
Subtle differences in the shape of the brain that are present in adolescence are associated with the development of psychosis, according to an international team led by psychiatrists at the University of Pittsburgh School of Medicine and Maastricht University in the Netherlands.
Despite decades of research and investment, the genetic underpinnings of Alzheimer’s disease are still largely unknown, stymieing drug development and early diagnosis efforts. A new $10.7 million, five-year project aims to change that.
Following chemo, survivors suffer with memory dysfunction. The first large-scale study underway on cognitive behavioral therapy.
VGLUT – a glutamate transporter on the membrane of vesicles that carry dopamine – is key to regulating sex differences in the brain’s vulnerability to age-related neuron loss.
Asthma exacerbations rose following a catastrophic Christmas Eve fire that destroyed pollution controls at the Clairton Coke Works – the largest such facility in the nation, a University of Pittsburgh Graduate School of Public Health analysis concludes.
The first large-scale, multi-hospital evaluation of an “all or none” federal policy intended to improve results in sepsis patients finds that the guidelines are a wash – on average they neither helped nor hurt outcomes despite significant investments in their implementation.
Research indicates the rate of cancer recurrence or survival may be no different in older women diagnosed with early breast cancer whether they were treated or untreated.
Wheezing, coughing that doesn’t stop, a pale and sweaty face: clinically, severe asthma attacks look very similar from patient to patient. But biologically, not all severe asthma is the same—and a team of scientists has, for the first time, identified the key difference in people, a finding that has important implications for treatment.
What can vaccine proponents, clinicians and public health communicators learn from “anti-vaxxers?” A lot, according to new guidance for pro-vaccination social media events written by University of Pittsburgh health scientists.
“Near-poor” Americans – people just above the federal poverty level but still well below the average U.S. income – who rely on Medicare for health insurance face high medical bills and may forgo essential health care, according to new research.
As evidence mounts supporting the use of monoclonal antibody treatment to reduce hospitalizations and deaths from COVID-19, UPMC and University of Pittsburgh School of Medicine physician-scientists are sharing the health system’s experience administering the life-saving medication.
‘Tissue-resident memory T cells’, whose main function is to provide local protection against re-infection, contribute to chronic transplant rejection.
A new survey of dozens of surge capacity managers at hospitals nationwide captures the U.S. health care system’s pandemic preparedness status in the months before the first COVID-19 cases were identified in China.
Women who experience an accelerated accumulation of abdominal fat during menopause are at greater risk of heart disease, even if their weight stays steady, according to a University of Pittsburgh Graduate School of Public Health-led analysis published today in the journal Menopause.
Researchers have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage, potentially using an existing medication.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right